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Abstract
Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression
of SOCS2 is regulated in human monocyte-derived DC by ligands stimulating TLR2, 3, 4, 5, 8 and 9 signaling. SOCS2
induction by LPS was dependent on the type I IFN regulated transcription factors IRF1 and IRF3 as shown by using silencing
RNAs for IRFs. Blocking endogenous type I IFN signaling, by neutralizing antibodies to the receptor IFNAR2, abolished
SOCS2 mRNA expression after TLR4 stimulation. Transcription factors STAT3, 5 and 6 displayed putative binding sites in the
promoter regions of the human SOCS2 gene. Subsequent silencing experiments further supported that STAT3 and STAT5
are involved in LPS induced SOCS2 regulation. In mice we show that SOCS2 mRNA induction is 45% lower in bone marrow
derived macrophages derived from MyD88
2/2 mice, and do not increase in BMMs from IRF3
2/2 mice after BCG infection. In
conclusion, our results suggest that TLR4 signaling indirectly increases SOCS2 in late phase mainly via the production of
endogenous type I IFN, and that subsequent IFN receptor signaling activates SOCS2 via STAT3 and STAT5.
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Introduction
Antigen-presenting cells (APCs) are able to recognize microbes
based on pattern-recognition receptors such as Toll-like receptors
(TLRs). The TLR family is widely expressed among inflammatory
cells and includes 11 members in humans and 13 in mouse [1,2].
Each TLR recognizes different microbial molecules resulting in
the recruitment of cytoplasmic adaptors to their Toll/IL-1
receptor (TIR) domain and subsequent activation of cellular
programs [2,3]. There are two major independent but comple-
mentary pathways in TLR signaling: (I) the MyD88-dependent
pathway, which recruits the adaptor MyD88 upon TLR2, 4, 5, 7,
8 and 9 activation or MyD88-adaptor like (MAL) upon TLR2 and
4 activation. The MyD88 dependent activation leads to NFkB,
AP-1, IFN regulatory factor 5 (IRF5) and IRF7 nuclear
translocation that controls the expression of inflammatory cytokine
genes such as TNFa, IL-1b and IL-12. (II) The MyD88-
independent pathway which induces the recruitment of the TIR
domain-containing adaptor (TRIF) upon TLR3 and 4 activation
and the TRIF related molecule (TRAM) adaptor upon TLR4
activation, leading to IRF3 nuclear translocation inducing the
expression of mainly type I IFN and IFN-inducible genes [4,5].
Recently, more members of the IRF family, IRF1 [6], IRF7 [7]
and IRF8 [8], have been demonstrated as important transcrip-
tional factors for the induction of type I IFN.
Evolution has developed several lines of negative regulation
mechanisms to keep TLR and ensuing inflammatory responses at
adequate levels. The involved negative regulators are divided into
2 groups: signal-specific regulators that inhibit signal transduction
by TLRs such as SOCS proteins and gene-specific regulators that
function to modulate gene expression [9]. The members of SOCS
family consisting of SOCS1-7 and cytokine-inducible Src homol-
ogy 2 protein (CIS) have been found to negatively regulate JAK-
STAT signaling. SOCS1 and 3 have been also shown to modulate
TLR4 signaling [10]. SOCS1 interacts with phosphorylated MAL
resulting in its polyubiquitylation and subsequent degradation by
the proteasome [11]. In addition SOCS1 and SOCS3 also inhibit
NF-kB activation and thereby regulate TLR4 signaling [12].
SOCS2 is a well established negative regulator of growth
hormone (GH) signaling via the JAK/STAT pathway [13] and
docks to the intracellular domains of related receptors or facilitates
proteasome-dependent degradation of transcription factors [14].
Recently, the action of the anti-inflammatory drug, acetylsalicylic
acid, was shown to be SOCS2-dependent, indicating an important
role of SOCS2 in the regulation of infectious and inflammatory
responses [15]. Furthermore, the HIV-1 transactivator protein
Tat, one of the retroviral proteins identified as a key immuno-
modulator in the pathogenesis of AIDS, interfered with the IFN-c
receptor signaling pathway at the level of STAT1 activation,
possibly via Tat-dependent induction of SOCS2 activity induced
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30166by HIV infection, again pointing towards SOCS2 as an important
modulator of immune responses [16].
SOCS2 has been shown to be induced by the TLR2 ligand
LXA4 in mouse splenic DCs [15] and the TLR4 ligand LPS in
human DCs [17]. However, the regulation of SOCS2 expression
by inflammatory stimuli in the cells of immune system has not
been extensively studied. In contrast, more in depth studies have
been performed on SOCS2 transcription in GH signaling. GH
signaling leads to SOCS2 transcription via induction of the
transcription factor STAT5b. A novel response element for
STAT5b was identified within the first intron of the human
SOCS2 gene, composed of an E-box followed by tandem STAT5b
binding sites, both of which are required for full GH responsive-
ness [18]. We previously reported that SOCS2 is substantially
induced by LPS stimulation in human monocyte derived dendritic
cell (moDCs) [17]. In this study, we further investigate the
transcriptional regulation of SOCS2 expression in TLR4 signal-
ing.
Results
TLR ligands induce SOCS2 gene expression in human
moDCs
Toll-like receptors recognize microbial patterns, and can be
arranged into three major families by their ability to bind lipids
(TLR2 and TLR4), proteins (TLR5) and nucleic acids (TLR 3, 7, 8
and 9) [4]. We first investigated the ability of different TLR agonists
to modulate SOCS2 expression in APCs. Human immature DCs
(iDCs) were obtained by differentiating monocytes with GM-CSF
and IL-4. On day6 the cells were stimulated with various TLR
ligands including Pam3CSK4 (TLR2), LPS (TLR4), flagellin
(TLR5), polyI:C (TLR3), imiquimod (TLR7), ssRNA40 (TLR8)
and ODN2336 (TLR9). Real-time PCR analysis demonstrated
significantly increased expression of SOCS2 mRNA levels 8 h to
24 h after stimulation by TLR2, TLR3, TLR4, TLR5, TLR8 and
TLR9 binding ligands (Figure 1A). Interestingly, stimulation by
Pam3CSK4 and LPS resulted in the highest SOCS2 mRNA
accumulation (23 and 48 fold increase). The SOCS2 induction was
moderate when iDCs was stimulated by either flagellin (7 fold),
polyI:C (6 fold), ssRNA40 (10 fold) or ODN 2336 (9 fold). SOCS2
mRNA level in DCs stimulated with TLR7 agonist was not
increased (Figure 1A). This was partially expected with regard to
TLR 7 signaling, since TLR7 has not so far been reported to be
expressed in human DCs [19] whereas the expression has been
demonstrated in mouse myeloid DCs [20].
SOCS2 protein levels were also increased in DCs incubated with
Pam3CSK4, PolyI:C, LPS, flagellin and ssRNA40 treatment
(Figure 1B) corresponding to the changes seen in the increased
SOCS2 mRNA expression levels (Figure 1A). The increased SOCS2
protein expression became obvious at 8 h and increased dramatically
up to 24 h. However, ODN 2336, the ligand for TLR9, did not
induce increased SOCS2 protein levels (Figure 1B right panel) in
contrast to results at the transcriptional level where a 10 fold
increased expression of SOCS2 message was demonstrated
(Figure 1A). Quantification of SOCS2 protein expression on
stimulatedmoDCsfromdifferenthealthyblooddonorsdemonstrated
a good correlation with the mRNA expression data with the
exception of TLR9 signaling. We conclude that TLR signaling
stimulates SOCS2 expression, with the dominant inducer being LPS.
Type I IFN regulated transcription factors are involved in
SOCS2 induction
Since LPS was found to be the main inducer of SOCS2
expression (Figure 1) we next studied SOCS2 transcriptional
Figure 1. Various TLR ligands induce SOCS2 gene expression in
human moDCs. (A). Human SOCS2 mRNA expression induced by
different TLR signaling. Enriched monocytes were cultured in the
presence of GM-CSF and IL-4 for 6 days. Quantitative real-time PCR was
used to measure SOCS2 mRNA expression in iDC after exposure to
Pam3CSK4 (TLR1/2), LPS (TLR4), flagellin (TLR5), polyI:C (TLR3),
imiquimod (TLR7), ssRNA40 (TLR8) and ODN 2336 (TLR9) for different
time periods. Data shown are the mean of triplicate determinations
from at least three donors. Values for the time point 0 were set to 1. (B,
C). SOCS2 protein expression levels after various TLR signaling stimuli.
Western Blotting analysis for protein of SOCS2 expression in iDCs
exposed to Pam3CSK4 (TLR1/2), LPS (TLR4), flagellin (TLR5), polyI:C
(TLR3), imiquimod (TLR7), ssRNA40 (TLR8) and ODN 2336 (TLR9) for
different time points. (B) Representative Western Blot for each typical
TLR signaling effect to SOCS2 expression. The data shown in (C) are the
mean of SOCS2 protein bands quantified from Western blots and
normalized to b-actin from four donors. Values for time point 0 were set
to 1. Error bars comparing different time point groups to the 0 time
point group illustrate s.d. * p,0.05; ** p,0.01.
doi:10.1371/journal.pone.0030166.g001
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dependent and -independent pathways [4]. In conventional DCs
(cDCs), LPS activates NF-kB as a part of the MyD88-dependent
pathway and IRF3, which regulates type I IFN transcription in a
MyD88-independent manner. Recently, also IRF1 has been
shown to have a role in type I IFN induction during activation
of the MyD88-dependent pathway [6]. iDCs were stimulated with
LPS and transcription factors involved in TLR4 signaling were
measured in nuclear fractions. P65NF-kB, IRF1 and IRF3
translocated from the cytoplasm to the nucleus after 30 minutes
to 1 h. Interestingly, NF-kB and IRF3 nuclear translocation
peaked around 1 h whereas IRF1 translocation peaked after 4 h
(Figure 2A).
In order to identify the transcriptional factors involved in
SOCS2 expression, we silenced p65NF-kB, IRF1 and IRF3 in
human moDCs with siRNA, and then stimulated the transfected
cells with LPS. Compared to control siRNA, all tested siRNAs
demonstrated an efficient knock-down of target gene expressions.
The range of knock-down efficiency was from 33 to 85%
(figure 2B–D right parts). Surprisingly, p65NF-kB knock-down
had no effect on SOCS2 induction (Figure 2B, left part). However,
IRF1 (Figure 2C, left part) and IRF3 (Figure 2D, left part)
silencing decreased SOCS2 induction significantly at the 24 h time
point. We conclude that IRF1 and IRF3 pathways mediate
SOCS2 expression.
Type I IFN is required for SOCS2 induction
Since the IFN response factors IRF1 and IRF3 regulated
SOCS2 expression we studied the role of IFNs as inducers of
SOCS2. The IFNs are classified into type I IFNs including a, b etc
more than 20 other subtypes, the single type II IFNc and three
type III IFNls [21,22]. We first investigated which type of IFNs
that might be involved in SOCS2 induction after TLR4 signaling
in human moDCs. After LPS treatment, we measured IFNa,
IFNb, IFNc and IFNl1 mRNA expression at different time
points. After 2 h, IFNb and IFNl1 mRNA were induced
dramatically, the levels were maintained until 81h and returned
to base line after 24 h (Figure 3A). IFNa showed a similar profile
except a later induction at 8 h instead of 2 h, whereas IFNc was
only moderately induced after LPS treatment (Figure 3A). These
results are consistent with previous findings [23].
To further clarify which IFN are able to induce SOCS2
expression, we treated moDCs with IFNa, IFNb, IFNc or IFNl1
respectively, and measured SOCS2 mRNA expression. IFNa
induced a small increase in SOCS2 expression (Figure 3Bi). In
contrast, both IFNb and IFNc showed a rapid and substantial
induction of SOCS2 expression after 1 h stimulation (Figure 3Bii–
iii). IFNl1 did not induce any SOCS2 increase (Figure 3Biv).
Taken together LPS induced IFNb and IFNb has the direct ability
to stimulate SOCS2 expression in human moDCs. Though
SOCS2 was induced around 5 folds after IFNb stimulation
(Figure 3Bii) but almost 50 folds in LPS treatment (Figure 1A), this
obvious difference of SOCS2 induction was most likely a
consequence that sustained LPS stimulation induces an IFN-
dependent amplification loop causing a production of large
amount of IFNb continuously. To further prove that endogenous
type I IFN production has a role for SOCS2 induction, we added
a neutralizing anti-human interferon-a/b receptor (IFNAR) 2
antibody before LPS activation of moDCs. The effect of IFNAR2
blocking was investigated after 4 h of stimulation, since our
previous data show that LPS induce a significant increase in
SOCS2 mRNA expression at that time point [17]. Addition of
anti-human IFNAR2 antibody blocked the SOCS2 mRNA
induction in response to LPS treatment, whereas incubation with
the isotype control antibody did not (Figure 3C). These suggest
that endogenous type I IFN mediates SOCS2 expression in
response to LPS.
Transcription factors STAT3, 5 and 6 are translocated to
the nucleus in response to LPS and IFNb
The TLR4 ligand LPS is a well known inducer of acute
inflammation. In APCs, several hundred genes are induced within
a few hours of LPS stimulation [24]. Dedicated transcription
factors coordinately regulate these gene sets or transcriptional
modules. The genes induced by TLR4 signaling can be grouped
into three classes based on time lapse after LPS stimulation. The
primary response genes are induced within 0.5–2 h, the secondary
response genes are induced after 2–8 h, and specific gene
expression is induced after a longer period of time [25]. Since
SOCS2 mRNA levels increased significantly after 4 h LPS
stimulation [17] and within 1 h after IFNb stimulation
(Figure 3Bii), we hypothesized that SOCS2 was induced by type
I IFN as a secondary response gene after LPS stimulation.
STATs are known as essential components of the type I IFN
receptor signaling cascade [21,26]. Therefore we decided to study
the human SOCS2 promoter region and search for potential
binding sites for STAT family members. Three promoter regions
(Figure S1A) in the SOCS2 gene were investigated. We found
several putative binding sites for STATs in the promoter regions 1,
2 and 3 (As shown in Figure S1B); STAT5 in the promoter region
1, STAT3 in the promoter region 2 and STAT3, 5, 6 in the
promoter region 3. Thus, STAT3, 5 and 6 were identified as
putative SOCS2 regulating transcriptional factors for type I IFN
signaling in human DCs. Therefore we addressed the role of these
transcription factors in SOCS2 induction in our experimental
system.
If STATs are transcriptional factors regulating SOCS2
induction after type I IFN signaling, i.e. the subsequent signaling
cascade of TLR4 signaling, the STATs should be activated after
type I IFN or LPS stimulation in a time correlated way. To prove
this, nuclear proteins were extracted from LPS or IFNb treated
iDCs at different time points and the nuclear translocation for the
predicted STAT3, 5 and 6 transcriptional factors was demon-
strated by Western Blot. The STAT3, 5 and 6 transcription factors
were all translocated into the nucleus 30 minutes after IFNb
stimulation (Figure 4A). However, the LPS induced translocation
occurred at 2 h for STAT3 and STAT5, and only weakly for
STAT6 at 1 h (Figure 4A). Thus, LPS induction of SOCS2 is most
likely dependent on IFNb and its subsequent activation of STAT3
and STAT5.
Transcription factors STAT3 and STAT5 are required for
SOCS2 induction
To further determine the role of predicted SOCS2 promoter
region binding transcription factors STAT3, STAT5 and STAT6
for the TLR4 signaling induction of SOCS2, we performed gene
silencing experiments using STAT3, STAT5 and STAT6 siRNAs
to check their effect on SOCS2 mRNA expression. When STAT3
expression was silenced, a significant reduction (.70% decrease)
of LPS induced SOCS2 mRNA expression was observed
(Figure 4B). A similar effect was found in STAT5 silenced moDCs
(.76% decrease) (Figure 4C). Consistent with our results of a weak
STAT6 nuclear translocation after LPS stimulation (Figure 4A)
successful silencing of STAT6 did not affect SOCS2 mRNA
expression (Figure 4D). Thus, Stat3 and Stat5 are most likely the
main transcription factors regulating SOCS2 induction after
TLR4 signaling.
SOCS2 Transcription Regulation in TLR Signaling
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involved in SOCS2 induction in mouse bone marrow
derived macrophages
To verify our findings in a more physiologically relevant
situation we studied BCG responses of bone marrow derived
macrophages (BMM) from MyD88
2/2 and IRF3
2/2 mice. BCG
stimulates TLR signaling, mainly by engaging TLR2 and TLR4
receptors followed by subsequent activation of MyD88-dependent
and -independent pathways, causing NF-kB and IRF3 nuclear
translocation [34,35].
In BMM from wild type mice, SOCS2 mRNA was induced
48 h after BCG infection (Figure 5). Unlike when tested in human
moDCs (Figure 2B), SOCS2 mRNA expression was abrogated
about 45% in BMM from MyD88
2/2 mice. However, SOCS2
induction was almost completely eliminated in BMM derived from
IRF3
2/2 mice (Figure 5). These results demonstrate that SOCS2
induction after BCG engagement is dependent on the IRF3/IFN
pathway and that both MyD88-dependent and –independent
pathways are involved.
Discussion
In this report, we demonstrate that expression of SOCS2 in
human moDCs is mediated by ‘‘endogenous’’ type I IFN signaling
after LPS treatment. SOCS2 is stimulated in a relatively slow
fashion, and inhibition of the IFNAR2 receptor signaling strongly
reduced the SOCS2 expression. Thus, although the promoter
region of SOCS2 contains a consensus sequence for IRF3 binding
(not shown), it is unlikely that direct IRF3 binding to the promoter
region of SOCS2 is an important regulatory mechanism.
Type I IFN has been shown to play an important role in the
cascade of gene expression after TLR signaling [22,24]. In
particular, TLR4 has been demonstrated to induce synthesis and
secretion of IFNb by APCs that secondarily stimulate the
expression of IFN-regulated genes [23,27] and in addition negative
regulators to adjust signaling [28]. Our data suggest that an
autocrine/paracrine type I IFN loop is required for LPS to
stimulate SOCS2 expression (Figure S2). A recent publication
suggested that SOCS2 is a direct downstream target of TLR
ligation [29]. However, the effect of IFN to SOCS2 induction was
not investigated. We clearly demonstrate that the inhibition of
IRF1, IRF3 and INFAR2 signaling severely impairs SOCS2
induction (Figure 2 and 3C). Though the siRNA experiments in
Figure 2 showed the effect of IRF1 and IRF3 for SOCS2
induction at the 24 h time point and the experiment in figure 1
using LPS activation of DCs responded already after 8 h, the
different experimental settings between the figures likely affected
the time courses. We have previously observed similar effect
caused likely by siRNAs transfection process [29]. In contrast to
IRFs, NF-kB silencing only marginally affected SOCS2 expression
in our study. This data demonstrates the importance of type I IFN
for the LPS induced SOCS2 in an indirect loop way.
The importance of IFN signaling for SOCS2 regulation was
further supported in IRF3 and MyD88 deficient mice experi-
ments. While MyD88 signaling only partially affects SOCS2
induction, SOCS2 induction was almost completely abolished in
IRF3 deficient macrophages (Figure 5). Compared to the former
human siRNAs knock-down experiments, SOCS2 expression was
induced in mice macrophages after 48 h BCG infection. It is most
likely caused by the different experimental systems including
species (human to mice), cells used (DCs to macrophages) and
stimulators (LPS to BCG). However, these also indicate that
SOCS2 expression is mainly induced in the late phase of infection
in an IFN-mediated manner.
IFNAR activation in the presence of LPS stimuli leads to
translocation of STATs, particularly STAT3 and STAT5
(Figure 4) followed by increased SOCS2 expression. Both IFNa-
and IFNb-dependent signals can activate STATs [21]. Stat5 is
phosphorylated on serines 725/730 and this is required for type I
interferon-dependent gene transcription via gamma interferon
activation site (GAS) elements [30]. STAT5 has previously been
demonstrated by our group to regulate mouse and human SOCS2
genes via binding to their promoter regions [18]. In agreement,
binding sites of STAT5 in the human SOCS2 gene can be
predicted (Figure S1) and may explain how SOCS2 is activated by
IFNb in human cells. Consistent with previous studies [29], we
show that STAT3 is activated by IFNb and is required for TLR-
dependent SOCS2 expression. This finding may contribute to the
understanding of the role of STAT3 activation in rendering DCs
ineffective [31].
The present study as well as a previous report [29] show that
signaling via other TLRs besides TLR4 increase SOCS2
expression. This may suggest that increased SOCS2 is of
importance for the control of host defense, i.e. by regulating
TLR signaling. TLR3, 8 and 9 agonists all enhance type I IFN
secretion by human DCs [6,32,33], providing a plausible
explanation for SOCS2 induction by those TLRs signals
(Figure 1). Interestingly, we found that TLR2 and TLR5
activation, which do not activate IFN secretion, also induced
SOCS2 expression in our study. It implied that besides IFN
signaling additional signals may be involved, and may also explain
why MyD88
2/2 BMM partly affect SOCS2 expression after BCG
infection (Figure 5).
The functional consequence of TLR activation of SOCS2 is
incompletely understood. Though the SOCS family has been
demonstrated to play a role as negative cytokine signaling
regulators, the data from SOCS deficient mouse models are in-
conclusive with varying immune response consequences. SOCS1
deficient mice were shown to be hyper-responsive to LPS and have
a high lethality when treated with LPS [34,35]. In contrast to this
SOCS3 deficient mice had reduced sensitivity to endotoxin shock,
resulting in a high survival rate after endotoxin treatment. This
was explained by an enhanced production of anti-inflammatory
cytokines including IL-6, IL-11 and LIF which normally are
inhibited by SOCS3 [36]. The phenotype of SOCS2 knockout
mice demonstrates increased sensitivity to GH, whereas changes in
immune system seem milder than with e.g. SOCS1. However, the
SOCS2 knock out mouse model provides a system where both
Figure 2. Type I IFN regulated IRFs, but not NF-kB were required for SOCS2 mRNA induction by TLR4 signaling in human moDCs. (A)
NF-kB, IRF1 and IRF3 nuclear translocation in TLR4 signaling in human moDCs. moDCs were stimulated with LPS at the indicated time points. Nuclear
protein was extracted for Western Blotting measurement. The levels of p65NF-kB, IRF1, IRF3 and Lamin A (as loading control) were detected. (B–D)
The effect of silencing NF-kB, IRF1 and IRF3 on the induction of SOCS2 mRNA in LPS stimulated human moDCs. moDCs were transfected with (B) NF-
kB, (C) IRF1, (D) IRF3 siRNAs or control siRNA and incubated for 24 hours. The transfected cells were exposed to LPS for 0 h, 8 h or 24 h, the cells were
then harvested for the mRNA measurement by qRT-PCR to demonstrate the effect of SOCS2 mRNA induction (left part) and efficiency of target gene
knockdown (right part). Data shown are representative of three independent experiments and are expressed as the –fold induction of the gene of
interest at different time points compared to time point 0 for control siRNA where the values were set to 1. Statstical significance comparing results
from the target siRNA to control siRNA group is indicated (* p,0.05; ** p,0.01).
doi:10.1371/journal.pone.0030166.g002
SOCS2 Transcription Regulation in TLR Signaling
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this may be relevant considering the increased awareness that
inflammatory disturbances are important in metabolic disorders
[37].
In conclusion, we demonstrate that various TLR ligands induce
SOCS2 gene expression in human DCs, and we propose that
SOCS2 regulation in late phase by TLR4 signaling is dependent
on an autocrine/paracrine type I IFN loop that activates SOCS2
via STAT3 and STAT5.
Materials and Methods
Ethics Statement
The work was approved by the Karolinska Institutet ethics
committees. The informed consent from all participants was
obtained and written for used human buffy coat (permit nr: 2008/
2017–31). All animal experimentations were conducted in
accordance with European and Swedish laws and regulation
(permit nr: N415/08).
Cell culture media, Cytokines and Reagents
L-glutamine, penicillin, streptomycin and FCS (Hyclone,
Logan, UT); Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden);
RPMI-1640 cell culture medium (Sigma-Aldrich, St Louis, USA);
Recombinant human GM-CSF and recombinant human IL-4
(Invitrogen Biosource, Camarillo, CA); and CD14
+ Human
monocyte isolation kit II (Miltenyi Biotec, Bergisch Gladbach,
Germany) were purchased from the sources as indicated for
human moDCs culture. Recombinant human cytokines IFNa,
IFNb1a, IFNc (R&D systems) and IFNl1 (PeproTech) were used
at optimal concentration of 1000 U/ml, 1000 U/ml, 20 ng/ml
and 3 nM, respectively. Mouse anti-human IFNAR2 neutralizing
antibodies (CD118; PBL Biomedical Laboratories, NJ, USA) and
mouse IgG2a isotype controls (R&D systems, USA) were used at
the concentration of 30 mg/ml.
Human moDCs were activated with the TLR2 ligand, 10 mg/
ml Pam3CSK4 (a synthetic bacterial tripalmitoylated lipopeptide);
TLR3 ligand, 30 mg/ml polyI:C (a synthetic analog of the
dsRNA); TLR5 ligand, 1 mg/ml purified flagellin (from S.
typhimurium); TLR7 ligand, 5 mg/ml imiquimod (small synthetic
antiviral molecule); TLR8 ligand, 5 mg/ml ssRNA40/LyoVec
(single-strand GU-rich oligonucleotide complexed with Lyo Vec);
TLR9 ligand, 5 mg/ml ODN 2336 (type A CpG oligonucleotide)
that were from InvivoGen (San Diego, CA, USA), and TLR4
ligand, 200 ng/ml LPS (derived from Escherchia coli O26: B6)
that was from Sigma-Aldrich (St Louis, USA). L-glutamine,
penicillin, streptomycin, FCS, Hepes and Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma, St Louis, MO) were used for
mouse cell culture.
Mice
Mutant mouse strains with genomic deficiency in MyD88 [38]
and IRF3 [39] were generated by homologous recombination in
embryonic stem cells as previously described. Animals were bred
and kept under specific pathogen-free conditions. Mice of the
C57BL/6 background were used as controls.
Figure 3. The effect of type I IFNs to SOCS2 mRNA induction in
human moDCs. moDCs were exposed to LPS (A) for indicated time
periods for mRNA measurement of IFNa, IFNb, IFNc and IFNl1o r
incubated with IFNa (Bi), IFNb (Bii), IFNc (Biii) and IFNl1 (Biv) for
indicated time periods for SOCS2 mRNA measurement by qRT-PCR. (C)
moDCs were pretreated for 30 min with or without 30 ug/ml
neutralizing anti-IFNR2 antibodies or IgG2a isotype control mAb and
then incubated for 4 h with or without LPS for SOCS2 mRNA
measurement by qRT-PCR. Data shown are representative of three
independent experiments and expressed as the –fold induction of the
gene of interest at different time points compared to time point 0
where the values were set to 1(A–B) or different treatment conditions
compared with medium that values were set to 1. Statistical
significance of results with anti-IFNAR2 mAb compared with control
mAb is indicated (C) (* p,0.05; ** p,0.01).
doi:10.1371/journal.pone.0030166.g003
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DCs were generated as previously described [17]. Briefly,
human PBMCs were isolated from fresh heparinized buffy coats
(Department of Transfusion Medicine, Karolinska University
Hospital) by Ficoll-Paque density gradient centrifugation. Human
monocytes (.95% CD14+) were negatively selected by magnetic
associated cell sorting (MACS) and subsequently cultured (10
6
cells/ml) in RPMI 1640 medium supplemented with 10% FCS,
50 ng/ml GM-CSF and 20 ng/ml IL-4 for 6 days. The cells were
fed with fresh medium on days 2 and 4. Immature DCs (1610
6/
ml) cultivated for 6 days as described above were incubated with
TLR ligands for different periods after an initial incubation for 1 h
in fresh supplemented RPMI 1640 medium or used for siRNAs
silencing experiments.
Mouse BM-derived Macrophages
Mouse BMMs were obtained from 6 to 10 week-old mice. Mice
were euthanized and the femur and tibia of the hind legs were
dissected. Bone marrow cavities were flushed with 5 ml cold,
sterile PBS. The bone marrow cells were washed and resuspended
in DMEM medium containing glucose and supplemented with
2 mM L-glutamine, 10% FCS, 10 mM Hepes, 100 mg/ml
streptomycin, 100 U/ml penicillin, and 20 to 30% L929 cell-
conditioned medium (as a source of macrophage-colony stimulat-
ing factor). Bone marrow cells were passed through a 70 mm cell
strainer, plated and incubated for 6 days at 37uC, 5% CO2. BMM
cultures were then washed vigorously to remove non-adherent
cells, trypsinized, counted and cultured for one day at 37uCi n6
well plates. We have previously shown by immunofluorescence
staining that these BMM are F4/80+, CD14+ and Mac-3+ [40].
Infection for mouse bone marrow-derived macrophages
Mycobacterium bovis BCG Montreal was grown in Middlebrook
7H9 (Difco, Carlsbad, CA) supplemented with albumin, dextrose,
catalase and 50 mg/ml hygromycin. BCG was grown to mid-log
phase, filtered through 40 mm cell strainers and the bacterial
concentration determined by spectrophotometry. BMMs were
infectedattheMOI5andsamplestakenattheindicatedtimepoints.
Transfection
Transfection of immature DCs(iDCs) was performed aspreviously
described [17] using a commercial kit and a nucleofector machine
(Amaxa Co., Ko ¨ln, Germany). According to the manufacturer’s
instruction, the iDCs were collected on day 6. 10
7 cells were
resuspended in 100 ml human DC nucleofection solution. Small
interfering RNAs (siRNA) (Qiagen, target sequences in Table 1) were
added, and the mixed samples were transferred into certified cuvettes
and transfected by using program U002. 500 mlp r e - w a r m e dR P M I
1640 medium, supplemented with 10% FCS, L-glutamine, penicillin
and streptomycin, was added to each cuvette after transfection. The
transfected cells were collected and seeded into wells of 6-well plates
containing supplemented RPMI 1640 medium with 50 ng/ml GM-
CSF and 20 ng/ml IL-4. After 24 hours, the cells were washed and
divided into several dishes for stimulation and analysis.
Figure 4. STAT3 and STAT5, but not STAT6 are required for SOCS2 mRNA induction in human moDCs. (A) STAT3 and STAT5, but not
STAT6 were translocated into the nucleus after IFNb or LPS stimulation. moDCs were incubated with IFNb or LPS at the indicated time points. The
cells were then harvested and nuclear proteins were extracted for Western Blotting measurement. The levels of STAT3, STAT5, STAT6 and LaminA (as
loading control) were detected. (B, C and D) STAT3 and STAT5, but not STAT6 gene silencing eliminates SOCS2 mRNA induction in TLR4 signaling.
moDCs were transfected with (B) STAT3, (C) STAT5 or (D) STAT6 siRNAs or control siRNA and incubated for 24 hours. The transfected cells were
exposed to LPS for 0 h, 8 h and 24 h, the cells were then harvested for the mRNA measurement by qRT-PCR to demonstrate the effect of SOCS2
mRNA induction (left) and efficiency of target gene silencing (right). Data shown are representative of three independent experiments and expressed
as the –fold induction of the gene of interest at different time points compared to time point 0 for control siRNA where values were set to 1.
Significance comparing results from the target siRNA to the control siRNA group is indicated (* p,0.05; ** p,0.01).
doi:10.1371/journal.pone.0030166.g004
**
**
*
Figure 5. IRF3, but not MyD88, mainly involved in SOCS2 mRNA expression after BCG infection in mice bone marrow macrophages
(BMM). BMM from wild-type mice, MyD88
2/2 mice or IRF3
2/2 mice were activated with BCG for indicated time periods, the cells were then
harvested for SOCS2 mRNA measurement by qRT-PCR. Data shown are the mean of triplicate determinations from three independent experiments.
Values for time point 0 were set to 1. Significance comparing results from the deficient mice to wild-type mice is indicated (* p,, 0.05; ** p,, 0.01).
doi:10.1371/journal.pone.0030166.g005
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Total RNA was extracted using TRIzol (Invitrogen). Total
RNA (1–3 mg) was treated with DNase I (Promega, Madison, WI)
and then reverse-transcribed with a cDNA synthesis kit (Bio-Rad,
Hercules, CA). The synthesized cDNA was used as template in a
real-time PCR mix according to the manufacturer’s standard
protocol (iQ SYBR Green supermix reagents). The reactions were
performed in a total volume of 20 ml with 2 ml of respective cDNA
sample (7500 fast real-time PCR system, Applied Biosystems). As a
control for the specificity of the real-time PCR a sample without
template was included. All the measurements were performed in
triplicates for each sample; the relative amounts of mRNA were
calculated with the comparative threshold (Ct) method and
normalized against human RP-II or mouse GAPDH. All primer
sequences are provided in Table 2.
Western blot analysis for SOCS2 protein or related
transcriptional factors nuclear translocation
After stimulation, DCs were washed once with cold PBS. Total
protein was extracted with radio immune precipitation assay
(RIPA) buffer and incubated on ice for 30 minutes. Nuclear and
cytoplasmic proteins were extracted using a commercial nuclear
and cytoplasmic protein extraction kit (Pierce Biotechnology,
Rockford, IL) according to the manufacturer’s instruction. A
protease inhibitor cocktail solution [Roche, Penzberg, Germany]
was added prior to usage.
The cell lysates (10–30 mg per lane) were submitted to SDS-
polyacrylamide gel electrophoresis (PAGE) (on 8–12% gels),
transferred to polyvinylidenediflouride (PVDF) membranes for
Western Blot analysis. After blocking with 5% fat-free milk
dissolved in TBS-T for 1 h at room temperature, membranes were
incubated over night with antibodies raised against total STAT3,
STAT5, STAT6, IRF3 and SOCS2 (Cell Signaling Technology,
Beverly, MA) and total p65NF-kB (BD Biosciences, Heidelberg,
Germany), IRF1 (Santa Cruz biotechnology, CA, USA) respec-
tively according to the manufacturer’s instructions. Binding of
these primary antibodies was visualized with goat anti-rabbit/anti-
mouse immunoglobulin coupled to horseradish peroxidase (Santa
Cruz biotechnology, CA, USA). After stripping, the membranes
were incubated and re-probed for new antibodies. Measurement
of Lamin A and b-actin proteins served as loading controls.
Bioinformatics and Statistical analysis
Genomic sequence of human SOCS2 promoters was obtained
from the UCSC Genome Bioinformatics Site (http://genome.
ucsc.edu). The prediction of transcription factor binding sites in
human SOCS2 promoters was performed using the binding sites
searching software (http://www.genomatix.de) for the STAT
family binding sites. Statistical comparisons between groups were
made by analysis of variance followed by a paired t test or student’s
t test. Statistical significance is indicated in the figures (*P,0.05;
**P,0.01).
Supporting Information
Figure S1 Prediction of putative SOCS2 gene promoter
binding transcription factors. (A) Diagram of the human
SOCS2 gene showing the position of the different promoter
regions and putative transcription factor binding sites. The thin
solid line represents the genomic regions containing the SOCS2
gene. Intermediary lines represent the locations of exons, whereas
the thick lines represent the translated regions. (B) Predicted
transcriptional factor binding sites in the SOCS2 gene promoter
regions.
(EPS)
Figure S2 Illustration of the proposed mechanism for
SOCS2 transcriptional regulation in TLR4 signaling. LPS
binds to the TLR4 on cell surface, and activates transcription
factors IRF1 and IRF3 which translocate into nucleus and cause
secretion of type I IFN. Autocrine-paracrine type I IFN activates a
subsequent signaling by the IFNAR and leads to translocation of
STATs, particularly STAT3 and STAT5 for increased SOCS2
expression.
(EPS)
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Table 2. Primers for real-time PCR amplification.
Forward (59-39) Reverse (59-39)
Human
SOCS2 GAGCTCGGTCAGACAGGATG AGTTGGTCCAGCTGATGTTTT
NF-kB CCCCACGAGCTTGTAGGAAAG CCAGGTTCTGGAAACTGTGGAT
IRF1 TGCCTCCTGGGAAGATGA CCTGGGATTGGTGTTATGC
IRF3 ACCAGCCGTGGACCAAGAG TACCAAGGCCCTGAGGCAC
IFNa AGCCATCTCTGTCCTCCATGA CATGATTTCTGCTCTGACAACC
IFNb GATTCCTACAAAGAAGCAGCAA CAAAGTTCATCCTGTCCTTGAG
IFNc GCAGGTCATTCAGATGTAGCGG TGTCTTCCTTGATGGTCTCCACAC
IFNl1 GTGGTGCTGGTGACTTTGG CTCCTGTGGTGACAGAGATTTG
STAT3 GGCCCCTCGTCATCAAGA TTTGACCAGCAACCTGACTTTAGT
STAT5 GTCACGCAGGACACAGAGAA CCTCCAGAGACACCTGCTTC
STAT6 CCTCGTCACCAGTTGCTT TCCAGTGCTTTCTGCTCC
RPII GCACCACGTCCAATGACAT GTGCGGCTGCTTCCATAA
Mouse
SOCS2 TCCAGATGTGCAAGGATAAACG AGGTACAGGTGAACAGTCCCATT
GAPDH TTGTCAAGCTCATTTCCTGGT TTACTCCTTGGAGGCCATGTA
doi:10.1371/journal.pone.0030166.t002
Table 1. Target sequences for siRNA.
NF-kB AAGATCAATGGCTACACAGGA
IRF1 CAGCCGAGATGCTAAGAGCAA
IRF3 CCGCTCTGCCCTCAACCGCAA
STAT3 CAGCCTCTCTGCAGAATTCAA
STAT5 CCGAGCGAGATTGTAAACCAT
STAT6 ACGGATAGGCAGGAACATACA
Negative Control siRNA AATTCTCCGAACGTGTCACGT
doi:10.1371/journal.pone.0030166.t001
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